Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on June 21, 2021. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Study for the Conversion of FDA DNA Signatures onto a Biosensor

Awarded
FDA-21-RFQ-1242990Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

Contract Value

$55,000

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

MD

Set-Aside

NONE

Award Issued Date

Documents

1

FDA-21-RFQ-1242990.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Combined Synopsis

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeBeltsville, MD, 20705, USA
Office AddressBeltsville, MD, 20705, USA

Full Description

Show more
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6 and 13.1 as supplemented with additional information in this notice. Quotes are being requested and this announcement constitutes the only solicitation. The Government contemplates issuing a firm fixed-price purchase order resulting from this solicitation. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2021-04 dated January 19, 2021. The associated North American Industrial Classification System (NAICS) code for this procurement is 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), with an associated size standard of 1,000 employees. In order to assist with onsite testing of FDA regulated products, the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM) requires a study to convert FDA DNA signatures/(FDA PCR assays) onto a biosensor assay. The assay will allow for rapid, sensitive, specific, and affordable verification of FDA regulated products. The contractor will be responsible for the modification and conversion of the FDA assays onto a biosensor. The use of the biosensor should exhibit similar performance (sensitivity and specificity) of the existing validated PCR methods for the detection of FDA DNA regulatory targets. The field-operable nano-biosensors will support CVM on several ongoing projects including analyzing regulatory samples. Please see the RFQ attachment for details.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541611
New
Federal
Contractor-Hosted Fully Integrated Records Facility (FIRF) IDIQ
Solicitation # 75F40126R00009
Solicitation 75F40126R00009 is a request for proposals for a single Indefinite Delivery, Indefinite Quantity (IDIQ) contract to provide Contractor-Hosted Fully Integrated Records Facility (FIRF) services for the FDA. This acquisition is exclusively set aside for Service-Disabled Veteran-Owned Small Business (SDVOSB) concerns under NAICS code 541611. The contract has a maximum ceiling of 50 million dollars with a guaranteed minimum of 10,000 dollars. The anticipated period of performance consists of five 12-month ordering periods from December 1, 2026, through November 30, 2031, with an additional six-month option to extend services through May 31, 2032. The contract will support various task order types, including Time-and-Materials, Labor-Hour, and Firm-Fixed Price. The scope of work requires the contractor to manage an offsite document control facility to standardize records management and transition the agency toward a near 100 percent electronic environment for premarket and postmarket submissions. Key task areas include program management, document processing, scanning, data entry, tracking, temporary storage, and transition activities. Performance will primarily occur at FDA facilities in the Washington, D.C. metropolitan area, specifically within Maryland. Award will be made on a Lowest Price-Technically Acceptable (LPTA) basis, evaluating technical factors and past performance on an acceptable or unacceptable basis. Proposals must be submitted electronically in three separate volumes, with a final submission deadline of November 5, 2026, at 2:00 PM Eastern Time.
Administrative Management and General Management Consulting Services

POSTED

1 day ago

DEADLINE

in 8 days
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS